Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report Research Letter


Authors: Kunvarjee, B.; Contreras Yametti, G. P.; Blouin, A. G.; Linder, G. E.; Borge, P. D.; Maryamchik, E.; Budhai, A.; Gupta, G. K.; Scaradavou, A.; Spitzer, B. G.; Curran, K. J.; Oved, J. H.; Harris, A. C.; Sharma, A.; Boelens, J. J.; Cancio, M. I.
Title: Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report
Keywords: clinical article; young adult; fludarabine; hydroxyurea; case report; rituximab; letter; quality of life; bortezomib; hemolysis; cyclophosphamide; dexamethasone; hematopoietic stem cell transplantation; monoclonal antibody; antibodies, monoclonal; donor; tissue donors; gene therapy; allogeneic hematopoietic stem cell transplantation; chronic pain; tacrolimus; hla antigen; hla antigens; sickle cell beta thalassemia; genotyping; sickle cell anemia; anemia, sickle cell; desensitization; mycophenolate mofetil; humans; human; male; plasma exchange; daratumumab; voxelotor; red blood cell distribution width; crizanlizumab
Journal Title: British Journal of Haematology
Volume: 204
Issue: 4
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2024-04-01
Start Page: 1540
End Page: 1544
Language: English
DOI: 10.1111/bjh.19289
PUBMED: 38212144
PROVIDER: scopus
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Maria I. Cancio -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics